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Abstract
We introduce a use case and propose a system for data
and knowledge integration in life sciences. In particular,
we focus on linking clinical resources (electronic patient
records) with scientific documents and data (research ar-
ticles, biomedical ontologies and databases). Our motiva-
tion is two-fold. Firstly, we aim to instantly provide sci-
entific context of particular patient cases for clinicians in
order for them to propose treatments in a more informed
way. Secondly, we want to build a technical infrastructure
for researchers that will allow them to semi-automatically
formulate and evaluate their hypothesis against longitudi-
nal patient data. This paper describes the proposed sys-
tem and its typical usage in a broader context of KI2NA,
an ongoing collaboration between the DERI research insti-
tute and Fujitsu Laboratories. We introduce an architecture
of the proposed framework called KI2NA-LHC (for Linked
Health Care) and outline the details of its implementation.
We also describe typical usage scenarios and propose a
methodology for evaluation of the whole framework. The
main goal of this paper is to introduce our ongoing work to
a broader expert audience. By doing so, we aim to establish
an early-adopter community for our work and elicit feed-
back we could reflect in the development of the prototype so
that it is better tailored to the requirements of target users.
1. Introduction
Health care presents a huge segment of the world econ-
omy and currently faces tremendous productivity chal-
lenges that are in no small part related to the recent data
explosion in the related fields. The health care stakehold-
∗The research and development presented in this paper have been sup-
ported by the KI2NA project, jointly funded by Fujitsu Laboratories Lim-
ited, IDA (Irish Industrial Development Agency) and SFI (Science Foun-
dation Ireland).
ers include pharmaceutical and medical product industries,
health care providers, staff and patients, each with different
interests and incentives. All of them generates vast pools of
data, typically disconnected from each other. The future of
data-intensive disciplines is in more efficient data sharing
and integration [14]. Interconnecting the life science data
repositories makes them much more actionable and useful
in practice, as follows from the generalisation of Metcalfe’s
law1 in the broader context of information networks [21].
Combination and aggregation of various types of health
care-related data provably leads to increases in productiv-
ity, reduction of the cost of health care processes and im-
provement of clinicians’ experience when dealing with the
data [4]. All of that is ultimately beneficial for the most
important thing in health care - treatment of the patients.
Examples of heterogeneous health care-related data in-
clude (but are not limited to): patient data coming from
various EHR management and clinical trial systems, ge-
netic testing vendors, longitudinal studies, epidemiological
databases and scientific resources (drug, protein and gene
databases, biomedical ontologies, etc.). Tighter integration
of all these types of data sources facilitates more informed
decision making for medical professionals who require var-
ious focused and personalised perspectives on the data re-
lated to the cases they currently deal with. More interlinked
biomedical resources are also beneficial for scientists in the
context of in-silico research with actual patient data, mak-
ing certain hypothesis instantly testable without a need for
tedious literature reviews and expensive experiments.
The concept of Linked Data [8] can facilitate more ef-
ficient (re)presentation and processing of biomedical re-
sources by uniform, standardised handling of the large,
dynamic and heterogeneous health care-related datasets.
Linked Data has growing enthusiastic support from industry
and academia. Its technical bases are the decentralised and
general architecture of the World Wide Web and a simple
format called RDF [11], suited for representation and anno-
1The value of a network is quadratic w.r.t. the number of its nodes.
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tation of globally interlinked data. The increasing number
of data exploitation techniques provided by the Linked Data
community naturally offers unprecedented possibilities also
for the biomedical data integration.
The main contribution of this paper is two-fold. Firstly,
we present two complementary use cases in biomedical data
integration that illustrate practical problems currently faced
by clinicians and biomedical researchers (Section 3). Sec-
ondly, we describe an architecture, core components and
ongoing evaluation of KI2NA-LHC, a system we currently
develop to realise the presented use cases (Section 4). The
system builds on several of our recent research projects that
are summarised in Section 2 (together with other related ap-
proaches). We conclude the paper in Section 5.
2. Related Work
Approaches related to our work can be classified in sev-
eral categories. For a uniform, simple and extensible repre-
sentation, storage and processing of data, we use the Linked
Data principles and technologies [8]. In particular, we ex-
tend the approach to distributed storage and dynamic query-
ing of linked data based on dataspaces [7], as elaborated
in [23] by our colleagues from the KI2NA collaboration.
In order to extract more complex knowledge patterns
from the relatively simple data, we build on the recent ad-
vances in the theory of distributional semantics [3], and,
in particular, on our work on distributional data seman-
tics [18, 17]. We combine this theoretical groundwork with
domain-specific approaches to data integration in life sci-
ences [4] and implement the result following the best prac-
tices in computer-based biomedical systems [22].
Regarding the user interface design and modes of typ-
ical user interaction, KI2NA-LHC combines principles of
knowledge-based publication search engines (e.g., Text-
presso [12], GoPubMed [5] or CORAAL [16]) and inter-
active data visualisation interfaces (see Exhibit [10], LOD-
Peas [9] and SKIMMR [15] for the most relevant ones).
Finally, concerning the deployment to end-users and
software integration, the KI2NA-LHC framework is being
implemented as a set of modules for GNU Health [1], a
state of the art system for clinical data management. The
tight software integration with GNU Health is one of the
key advantages of KI2NA-LHC, as it makes the novel auto-
mated services available to practitioners within an environ-
ment they are already used to. To the best of our knowledge,
this is a feature missing in all related approaches as of now.
3. Use Cases
The high-level goal of KI2NA-LHC is to enable better
integration of clinical data (e.g., electronic health records,
longitudinal studies and/or clinical databases) with related
information present in scientific resources (e.g., research ar-
ticles, biomedical databases, ontologies, and corresponding
Linked Open Data resources). Better integration allows for
more efficient ways of exploring the context related to par-
ticular information on bed (clinical) and bench (research)
side. In the following, we illustrate typical usage scenarios
for KI2NA-LHC concerning both of these aspects (in Sec-
tions 3.1 and 3.2, respectively).
To specifically illustrate the use case throughout the sec-
tion, we are going to use an example user, Alice. As an in-
tern in a hospital who just finished her entry-level medical
education, she is involved in daily clinical practice, but also
does biomedical research as a part of further postgraduate
education. Alice has specialised in viral infections before,
however, she is currently dealing with AIDS patients. Since
AIDS is related not only to virology, but also to many other
fields of biomedicine (such as pharmacology, immunology
or genetics), she often needs to consult a lot of resources
outside of her primary expertise and thus presents a type of
user who benefits most from the KI2NA-LHC technology.
3.1. KI2NA-LHC for Clinicians
The clinical usage scenario is motivated by adverse drug
reactions, which can have serious consequences both for
patient safety [2] and for economical impact of the asso-
ciated health care services [20]. Apart of their general sig-
nificance, adverse drug reactions also seem to be a substan-
tial risk for AIDS patients undergoing antiretroviral ther-
apy [13]. If one wants to prevent an outbreak of such an
adverse event or manage it once it happens, it is necessary
to explore possibly large amount of resources very quickly
in order to minimise the impact on the patient.
To illustrate the situation in detail, imagine Alice is
treating Bob, a recently admitted HIV-positive patient
who has just experienced acute AIDS onset. After ad-
mission and initial check that confirmed high potential
for resistance against antiretroviral monotherapy (i.e., us-
ing just one drug), Bob has been prescribed Zidovu-
dine/Lamivudine/Abacavir, which is a mix of three an-
tiretroviral drugs aimed to cope with resistant HIV strains
due to complementary effects of the particular drugs.
However, Bob quickly develops lipodystrophy (abnor-
mal transformations and shifts of fat tissue in his body). As
this fact is put into his patient record, it gets processed by
KI2NA-LHC and Alice can immediately see lipodystrophy
as a likely adverse effect associated with Abacavir accord-
ing to many clinical studies. When she explores that link
further, other information related to Abacavir appears, in-
cluding increased risk of heart attack which is marked as
especially relevant to Bob. Another significant fact in the
related information is genetic screening for the presence of
the HLA-B*57:01 allele. This is due to the fact that the
KI2NA-LHC system automatically integrated data from the
following resources: (i) Bob’s patient record which indi-
cates hypertension and thus higher susceptibility to the de-
velopment of coronary diseases; (ii) Biomedical publica-
tions which suggest strong relation between the presence of
the HLA-B*57:01 allele and hypersensitivity to Abacavir;
(iii) An alert of FDA (U.S. Food and Drug Administration
agency) that suggests genetic screening for the presence of
the HLA-B*57:01 allele in AIDS patients to be treated with
Abacavir.
After a quick study of the few original sources returned
by KI2NA-LHC as directly related to the case, Alice finds
out that the risk of severe adverse effects in Bob’s case is
indeed very high. She performs genetic screening of Bob
and confirms the suspect allele, therefore she recommends
a rapid switch to another mixture of antiretroviral drugs that
does not contain Abacavir or similar substances.
This example shows how a routine update of patient’s
record with a relatively minor issue led to an instant
serendipitous discovery of a potentially much more serious
adverse effect that could manifest itself in near future. With
KI2NA-LHC, Alice was not only able to identify that risk
in an early stage, but also to automatically retrieve relevant
material, study it in detail and propose further steps to con-
firm the risk and ensure it is remedied. Doing the same
with the current technologies is not impossible, however,
the process usually involves much more time and manual
effort, while also being more error- and omission-prone. At
a global scale, this leads to sub-optimal health care with po-
tentially preventable severe consequences.
Other general benefits of the emerging KI2NA-LHC
platform for clinicians like Alice are: (1) Immediate access
to summaries of cutting-edge scientific results related to
particular clinical cases (providing broader context for busy
clinicians who cannot read hundreds of papers at a time al-
though it may improve their decision making capability).
(2) Semi-automated diagnosis of a disease and retrieval of
related treatment information using records or social media
‘life logs’ of patients previously exhibiting similar symp-
toms (decision support). (3) Automated alert services (for
instance, if a stream of data from a patient suddenly exhibits
a pattern previously identified as potentially life-threatening
in literature).
3.2. KI2NA-LHC for Researchers
As Alice is not only an aspiring clinical expert, but also
a researcher, she is concerned about the scientific aspects of
AIDS as well. One of her research interests is the activity
of APOBEC family of proteins2 during the HIV transcrip-
2Enzymes that help generate protein diversity in mRNA editing, see
http://en.wikipedia.org/wiki/APOBEC for details.
tion process. She suspects that certain interleukins, such
as IL-27, may be related to the concerned APOBEC activ-
ity, but she is not sure how to prove it due to her limited
experience in genetics. Yet when exploring the literature
using KI2NA-LHC interfaces, she quickly discovers that
APOBEC3G, a specific member of the APOBEC protein
family, is frequently related to HIV, and that its gene ex-
pansion is semantically related to IL-27. She can then fetch
the articles directly related to these facts and study them in
detail. The whole process takes less than one minute with
KI2NA-LHC, which saved Alice a lot of time she would
need to spend otherwise, either tediously browsing through
heaps of largely irrelevant literature or actually designing
and performing the corresponding experiments.
The general benefits of KI2NA-LHC for the user group
consisting primarily of biomedical scientists and pharma-
ceutical researchers like Alice are mainly the following:
(1) Facility for semi-automated testing of hypotheses using
both laboratory/experimental and clinical data. (2) Auto-
mated identification of clinical cases related to a research
phenomenon (e.g., side effects in patients being treated
by an already used drug that contains compounds present
in a currently researched derivative drug); (3) Tools for
symbolic analysis of prevalent trends and patterns in large
amounts of semi-structured or unstructured patient data.
(4) Identification of a genome pattern which is a cause of
disease by statistical and symbolic analysis of the “omics”
data incorporated in KI2NA-LHC.
4. Implementation of KI2NA-LHC
The architecture of the KI2NA-LHC framework is de-
picted in Figure 1, which gives an overview of the data
being processed by the system, the essential modules and
the two general types of expected users. Generally speak-
Figure 1. Architecture of KI2NA-LHC
ing, KI2NA-LHC first digests various data related to health
care and biomedical research. It converts them to one uni-
form format (RDF [11]), representing everything as binary
relationships possibly augmented by meta-data like prove-
nance, time, location or certainty. The RDF data are stored
and indexed in a cloud-based repository. From the rela-
tively simple statements in the RDF repository, we compute
more expressive knowledge patterns (e.g., semantic similar-
ity, conceptual clusters of terms, taxonomies or rules). This
knowledge is then served to users via two different user in-
terfaces (one for clinicians, one for researchers). The users
can also provide us with a feedback on the content quality
which is consequently propagated back into the data store.
In the rest of the section, we provide specific details
on the types of data being ingested by KI2NA-LHC (Sec-
tion 4.1), the particular modules (Sections 4.2-4.4). Last
but not least, we comment on the development and deploy-
ment process in Section 4.5 and on ongoing evaluation in
Section 4.6.
4.1. Data and its Pre-Processing
The data being processed by KI2NA-LHC can be split
into several categories:
1. Clinical data: Initially, we are processing sample
patient data from iDASH, an open repository of real, yet
anonymised clinical data (cf. http://idash.ucsd.
edu/idash-data-collections; regarding the par-
ticular data sets, we focus primarily on MT Sample Data,
DMITRI Study Data Set and CDWRnotes). This allows us to
develop and test the system with realistic and readily avail-
able content without dealing with the complex legal and pri-
vacy issues usually associated with using raw patient data.
However, we are able to include arbitrary patient data as
they become available. This can be easily done through the
clinical data management system we use as the core plat-
form in KI2NA-LHC (see Section 4.5 for details).
2. Biomedical research articles: To provide
scientific context of the processed biomedical data,
we employ the Entrez API to PubMed and Pub-
MedCentral, open repositories of biomedical abstracts,
fulltexts and bibliographical information (see http:
//www.ncbi.nlm.nih.gov/pubmed and http://
www.ncbi.nlm.nih.gov/pmc/ for details).
3. Linked Open Data: There is an increasing num-
ber of freely available biomedical resources published as
Linked Open Data (cf. http://linkeddata.org/).
In particular, we incorporate relevant resources offered by
the Bio2RDF initiative (cf. http://bio2rdf.org/),
and the drug-related data sets listed at http://www.w3.
org/wiki/HCLSIG/LODD/Data. In addition to the
data presently being part of the Linked Open Data cloud,
we also process content stored in traditional databases (such
as the Genome database, cf. http://www.ncbi.nlm.
nih.gov/genome) and convert it to RDF/Linked Data
using the D2R tool developed by our colleagues (cf. http:
//d2rq.org/).
4. Social media: Since a lot of valuable information
about patients’ conditions, subjective assessments and im-
plicitly relevant facts is available on popular social networks
nowadays, we are going to process that type of data as well
(focusing primarily on Twitter and Facebook). Initially, we
take into account only feeds from pre-defined sets of volun-
teer user accounts in order asses the relative amount of use-
ful content we can get this way. In future (if social media
will be deemed a promising source of relevant and reliable
information), we plan to sieve through arbitrary content on
the social networks to aggregate population-wide ‘life logs’
of clinically relevant information.
As we use the Linked Data principles for uniform stor-
age of the content to be processed by KI2NA-LHC, we need
to convert all data to the RDF format. For the patient data
we use one of the best practices recommended by the stan-
dardisation organisation W3C. In particular, we follow the
design pattern 2, use case 3 described in [19]. The pattern
allows for representing each observation or record about a
patient (which has possibly multiple facets like time when
taken, value measured, type of the measurement, etc.) as a
set of binary relationships in RDF.
The Linked Open Data resources are already in the
RDF format and therefore no pre-processing is neces-
sary. For natural language text fetched from the biomed-
ical articles or social networks, we use the co-occurrence
analysis and relation extraction techniques that we de-
scribe in [17]. The result of this process is a CSV
file with subject, predicate, object, provenance, weight
records that represent the extracted relationships together
with their provenance (the textual resource they were ex-
tracted from) and confidence weight (how statistically sig-
nificant they are). This data is then converted to the
observation-based RDF format mentioned above.
Whenever applicable, the data being processed is
mapped to unique identifiers used in the standard biomedi-
cal data sets (as fetched from the Linked Open Data cloud).
This holds especially for entities like drug, gene, protein or
molecule names. The mapping process can utilise the def-
initions and synonym extensions of the terms in the linked
data sets in order to map their unique identifiers to lexically
similar terms extracted from the less structured data (e.g.,
texts or patient records).
4.2. Storing and Accessing the Data
The RDF data produced in the previous step is continu-
ously incorporated into an in-house RDF store hosted in the
Fujitsu Global Cloud (cf. http://en.wikipedia.
org/wiki/Fujitsu_Global_Cloud_Platform).
The implementation of the cloud-based RDF store is
part of the novel data management infrastructure jointly
developed by DERI and Fujitsu. It provides for scalable
and universal data storage and retrieval by combining the
notion of dataspaces [7] from the classical databases with
the Linked Data principles [8] and web architecture. The
technology builds on the recent research introduced in [23]
by a member of the DERI-Fujitsu team.
4.3. Extraction, Integration and Analysis
The data indexed in the cloud-based RDF store are fur-
ther analysed by our framework for emergent knowledge
extraction and processing, based on the research presented
in [18, 17]. The framework makes use of a universal, tensor-
based distributional [3] representation of simple binary
statements (essentially a 3-dimensional array of weights as-
sociated with the statements and indices corresponding to
the particular arguments of the statements). This 3D rep-
resentation can be converted to various 2D matrix perspec-
tives (i.e., sets of row or column vectors), which can in turn
be analysed by state of the art methods from linear algebra
(e.g., vector comparison or matrix decomposition). Such
analysis can discern various semantic phenomena emerging
from the simple data, like: (1) implicit similarity relation-
ships between terms; (2) clusters of similar terms forming
concepts; (3) co-occurrence patterns that can be interpreted
as domain-specific relationships (such as causality, regula-
tion or expression); (4) taxonomical hierarchy of the con-
ceptual clusters; (5) IF-THEN rules. The discovered pat-
terns can then be represented as new RDF statements about
the original data and fed back into the central RDF store.
4.4. User Interaction
Two minimalistic user interfaces are currently being
elaborated for KI2NA-LHC – one for clinicians and one
for researchers. The clinical interface has to be optimised
for both computers and hand-held devices in order to sup-
port the clinicians everywhere (e.g., even when visiting the
patients). It consists of a simple search box where free-text
queries on diseases, symptoms, drugs, genes, etc. can be en-
tered. The system then fetches all information that relates to
the query from the underlying RDF store, post-processes it
via the knowledge analysis module (ranking the statements
according to their relevance), and displays it to the user in an
interactive visualisation. The interface extends our current
tool SKIMMR [15], mostly by providing more convenient
user interaction and additional dynamic visualisations.
The research interface is slightly more complex – it al-
lows for graphical formulation of hypothesis in the form
of relations between biomedical entities and their logical
combinations. These hypothesis are then converted into
queries and get evaluated against the knowledge stored in
the KI2NA back-end. The result is a numerical assessment
of the plausibility of the hypothesis, as well as an interactive
visual summary of the related information fetched from the
back-end (re-using the result presentation from the clinical
interface).
Both interfaces allow users to provide a simple feedback
by giving a ‘thumbs-up’ or ‘thumbs-down’ to particular re-
sults. This information then gets propagated in the back-end
knowledge base, improving its quality in time.
4.5. Development and Deployment
The KI2NA-LHC system is being implemented as a set
of extension modules for the free and open source GNU
Health system [1], which is being used by many hospitals
(especially in developing countries) and also by the United
Nations University. GNU Health serves as a general wrap-
per for our back-end and as a basic interface between our
data processing components and the patient records. We
also make use of the existing user interfaces in GNU Health
in order to incorporate our user interaction modules into a
type of framework clinicians are used to. This allows us
to keep the learning curve for the new technology feasible,
which in turn leads to improved practical applicability.
4.6. Ongoing Evaluation
In order to test the KI2NA-LHC prototype, we are go-
ing to recruit sample users (via the GNU Health commu-
nity and dissemination at related conferences) from the very
early stages of development. This is to help us in continu-
ous evaluation of the underlying technologies, so that we
can dynamically implement any features implied either by
explicit requests or by the results of the evaluation.
The ongoing evaluation is two-fold, focusing on quanti-
tative and qualitative aspects. For quantitative evaluation,
we can compare samples of the automatically computed
statements in the KI2NA knowledge base with a golden
standard, for which we primarily use existing biomedical
vocabularies (e.g., MeSH, see http://www.nlm.nih.
gov/mesh/ for details). We also need to build our own
gold standard with the sample users, though, in order to
evaluate more complex phenomena and knowledge pat-
terns not captured by resources like MeSH. The comparison
with gold standard supports computation of objective qual-
ity measures – generalised precision and recall, following
the evaluation techniques proposed for tasks like ontology
matching [6].
We also address the qualitative evaluation to assess the
general applicability and industrially-relevant performance
of the platform. For this we employ usability surveys
based on the standard SUS methodology (System Usabil-
ity Scale, cf. http://en.wikipedia.org/wiki/
System_usability_scale). In addition, we will pro-
duce a clearly defined set of tasks and corresponding results,
and measure performance of our sample users in these tasks
(tracking time spent and results achieved). We will com-
pare their performance when using KI2NA-LHC and a set
of related state of the art solutions (such as GoPubMed [5]),
which will assess the practical contribution of our new sys-
tem.
5. Conclusions and Future Work
We introduced the KI2NA-LHC framework aimed at
data integration and semi-automated knowledge discovery
in life sciences. The practical relevance of the framework
was illustrated by two realistic use cases involving clini-
cal and research aspects of biomedical data integration. We
described the architecture of KI2NA-LHC and outlined the
details of its implementation based on our recent research
integrated into a state of the art biomedical data manage-
ment tool, GNU Health.
KI2NA-LHC is an on-going project that only started in
the end of year 2012, however, the system builds on a sound
basis of previously published work and implemented re-
search prototypes. Therefore the bulk of the technical fu-
ture work revolves around software integration of the al-
ready available components into the architecture scheme
presented in this paper. This will make the results of our
research readily available to end users, which is what mat-
ters most in the area of computer-based medical systems.
Apart of the development, we need to work on continu-
ous evaluation of the platform’s performance. This will be
done with sample users, following the agile software devel-
opment methodology (i.e., working with users from early
stages of the development and dynamically incorporating
their feedback into the evolving prototype).
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